Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions—a narrative review
- DOI
- 10.1186/s12916-026-05099-x
- Published
- 2026-08-05
- Container
- BMC Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12916-026-05099-x,
title = {Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions—a narrative review},
author = {Yang Cao and Xiong-Fei Xu and Ning Ma and Jie Gao and Li-Jiao Cui and Betty Yuen Kwan Law and Vincent Kam Wai Wong},
year = {2026},
journal = {BMC Medicine},
doi = {10.1186/s12916-026-05099-x},
url = {https://doi.org/10.1186/s12916-026-05099-x}
}RIS
TY - JOUR TI - Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions—a narrative review AU - Yang Cao AU - Xiong-Fei Xu AU - Ning Ma AU - Jie Gao AU - Li-Jiao Cui AU - Betty Yuen Kwan Law AU - Vincent Kam Wai Wong PY - 2026 JO - BMC Medicine DO - 10.1186/s12916-026-05099-x UR - https://doi.org/10.1186/s12916-026-05099-x ER -
APA
Cao, Y., Xu, X., Ma, N., Gao, J., Cui, L., Law, B. Y. K., & Wong, V. K. W. (2026). Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions—a narrative review. BMC Medicine. https://doi.org/10.1186/s12916-026-05099-x
Source records
- crossref · retrieved 2026-11-06T00:57:02.798Z